Valuation : Senzime AB

Market Cap 54Cr 5.55Cr 4.78Cr 4.53Cr 4.1Cr 7.7Cr 530.14Cr 7.74Cr 21Cr 269.71Cr 21Cr 20Cr 852.25Cr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 54Cr 5.55Cr 4.78Cr 4.53Cr 4.1Cr 7.7Cr 530.14Cr 7.74Cr 21Cr 269.71Cr 21Cr 20Cr 852.25Cr EV / Sales 2026 *
4.21x
EV / Sales 2027 * 2.64x
Free-Float
40.74%
Yield 2026 *
-
Yield 2027 * -
1 day+7.72%
1 week+4.27%
Current month-3.80%
1 month-12.87%
3 months-20.28%
6 months-25.41%
Current year-36.67%
1 week 3.03
Extreme 3.03
3.6
1 month 3.03
Extreme 3.03
4.06
Current year 3.03
Extreme 3.03
6
1 year 3.03
Extreme 3.03
6.68
3 years 3.03
Extreme 3.03
9.6
5 years 2.6
Extreme 2.605
24.8
10 years 2.6
Extreme 2.605
28.5
Manager TitleAgeSince
Chief Executive Officer 53 03/05/2023
Director of Finance/CFO 56 01/01/2022
Chief Tech/Sci/R&D Officer 50 01/01/2023
Director TitleAgeSince
Chairman 53 03/05/2023
Director/Board Member 70 01/01/2016
Director/Board Member 63 05/03/2020
Date Insider Type Main position Quantity % Market Cap. Importance
09/12/25 Buy

Director

15,000 0.0095%
09/12/25 Sell

Director

15,000 0.0095%
28/11/25 Buy

Director

15,900 0.0101%
Change 5-day change 1-year change 3-year change Capi.($)
+7.72%+4.27%-47.06%-34.73% 5.55Cr
-1.36%-5.89%-23.76%-0.44% 18TCr
-0.72%-3.41%-3.26%+12.32% 12TCr
+0.19%-2.83%+6.30%+80.17% 6.14TCr
-1.92%-6.01%+7.05%+38.44% 4.94TCr
+0.81%-3.73%-4.81%-32.56% 4.84TCr
-1.75%-5.54%+8.93%-20.82% 3.13TCr
+0.43%-11.10% - - 2.86TCr
+0.58%+1.84%+36.58%-12.08% 2.44TCr
+0.49%-7.65%-13.30%+3.79% 2.16TCr
Average +0.45%-4.15%-3.70%+3.79% 5.58TCr
Weighted average by Cap. -0.69%-4.90%-6.02%+10.83%

Financials

2026 *2027 *
Net sales 13Cr 1.32Cr 1.14Cr 1.08Cr 97.46L 1.83Cr 125.91Cr 1.84Cr 4.91Cr 64Cr 4.95Cr 4.84Cr 202.41Cr 20Cr 2.11Cr 1.81Cr 1.72Cr 1.56Cr 2.92Cr 201.14Cr 2.94Cr 7.84Cr 102.33Cr 7.91Cr 7.73Cr 323.35Cr
Net income -6.89Cr -71.11L -61.27L -58.01L -52.58L -98.65L -68Cr -99.15L -2.65Cr -35Cr -2.67Cr -2.61Cr -109.21Cr -3.68Cr -37.98L -32.72L -30.98L -28.08L -52.69L -36Cr -52.96L -1.42Cr -18Cr -1.43Cr -1.4Cr -58Cr
Net Debt - -
Logo Senzime AB
Senzime AB (publ.) is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.
Employees
59
Date Price Change Volume
11/26/11 SEK 3.420 +7.72% 4,52,103
10/26/10 SEK 3.175 +1.93% 2,00,813
09/26/09 SEK 3.115 +1.47% 1,93,358
08/26/08 SEK 3.070 -5.39% 1,88,519
07/26/07 SEK 3.245 -1.07% 1,62,622

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEZI Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!